73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Exploiting the synergy of nutraceuticals for cancer prevention and treatment

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including
ASCO endorses SIO guideline for integrative Tx in breast cancer

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat
A blood sample 24 hours after the start of chemotherapy can predict survival

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w
Differences in T cells' functional state determine resistance to cancer therapy

Differences in T cells' functional state determine resistance to cancer therapy

by Massachusetts Institute of TechnologyThe researchers took this image of a tumor using immunofluorescence, a technique that allows them to stain tissue sections with fluorescently-labeled antib

Differences in T cells' functional state determine resistance to cancer therapy

by Massachusetts Institute of TechnologyThe researchers took this image of a tumor using immunofluorescence, a technique that allows them to stain tissue sections with fluorescently-labeled antib
Discovery of drug candidate to potentially tackle ER-positive breast cancer

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University
Genetic test could guide use of cancer chemotherapy

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations
Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t
Boosting immunotherapy in non-responsive cancer cells

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca
A new therapeutic target turns the immune system against lymphoma

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im
Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi
Researchers discover source of deadly fungal infections in bone marrow transplant patients

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei
American cancer survivors face substantial financial hardship and financial sacrifices

American cancer survivors face substantial financial hardship and financial sacrifices

byAmerican Association for Cancer ResearchAmerican cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending, savings, or

American cancer survivors face substantial financial hardship and financial sacrifices

byAmerican Association for Cancer ResearchAmerican cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending, savings, or